Analyst stock forecast
BioCryst Pharmaceuticals Stock Forecast and Analyst Price Target
BCRX analyst target range, upside, consensus rating and coverage count.
Direct answer
BioCryst Pharmaceuticals's average price target is $20.82.
The target implies +96.6% from the recorded current price, and the consensus rating is Strong Buy.
The verified range is $12.00 to $32.00, with 11 analysts in the current consensus when available.
Forecast evidence checked August 13, 2026.
Get free BioCryst Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $10.59
- Average price target
- $20.82
- High price target
- $32.00
- Low price target
- $12.00
- Target upside
- +96.6%
- Consensus rating
- Strong Buy
- Analysts
- 11
- Evidence date
- August 13, 2026
- Valid through
- August 20, 2026